Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Cheung
    Cheung
  8. Voss
    Voss
  9. O'Reilly
    O'Reilly
  10. Robson
    Robson

Groups

  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)
  7. Epidemiology and Biostatistics (151)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (121)
  10. Surgery (118)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2025 (28)
  2. 2024 (63)
  3. 2023 (45)
  4. 2022 (123)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (404)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (46)
  5. Journal of Hematology & Oncology (42)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J.; Dong, Z.; Soloman, S. B.; Patil, S.; Hudis, C. A.; Wolchok, J. D.; Norton, L.; McArthur, H. L.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
    Meeting Abstract

    Sharma, M.; Shinde, R.; McGaha, T.; Huang, L.; Holmgaard, R.; Wolchok, J.; Mautino, M.; Celis, E.; Sharpe, A.; Francisco, L.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival
    Meeting Abstract

    Pesonen, S.; Lundin, J.; Linder, N.; Turkki, R.; Ristimäki, A.; Joensuu, T.; Kairemo, K.; Partanen, K.; Alanko, T.; Jäger, E.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group
    Journal Article

    Laszlo, G. S.; Alonzo, T. A.; Gudgeon, C. J.; Harrington, K. H.; Kentsis, A.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Raimondi, S. C.; Hirsch, B. A.; more...
    Journal of Hematology & Oncology (2015)

    Fulltext@MSK | Save
  • Direct ChIP-Seq significance analysis improves target prediction
    Conference Paper

    Bansal, M.; Mendiratta, G.; Anand, S.; Kushwaha, R.; Kim, R. H.; Kustagi, M.; Iyer, A.; Chaganti, R. S. K.; Califano, A.; Sumazin, P.
    Biomed Central Ltd (2015)

    Fulltext@MSK | Save
  • Who and when should we screen for prostate cancer? Interviews with key opinion leaders
    Journal Article

    Carlsson, S.; Leapman, M.; Carroll, P.; Schröder, F.; Albertsen, P. C.; Ilic, D.; Barry, M.; Frosch, D. L.; Vickers, A.
    BMC Medicine (2015)

    Fulltext@MSK | Save
  • Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells
    Journal Article

    Matevossian, A.; Resh, M. D.
    Molecular Cancer (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
    Meeting Abstract

    Ratner, L.; Ramos, J. C.; Noy, A.; Barta, S.; Parikh, S.; Phillips, A.; Ambinder, R.; Rauch, D.; Harding, J.; Baydoun, H.; more...
    Retrovirology (2015)

    Fulltext@MSK | Save
  • Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
    Meeting Abstract

    Phillips, A.; Fields, P.; Hermine, O.; Taylor, G. P.; Delioukina, M.; Horwitz, S.; Ramos, J. C.; Meniane, J. C.; Barta, S. K.; Brites, C.; more...
    Retrovirology (2015)

    Fulltext@MSK | Save
  • Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissue
    Journal Article

    Kleen, T. O.; Yuan, J. D.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save